| 沸点 | 623.7° C at 760 mmHg |
| 熔点 | 59.5-60.5° C |
| 折光率 | 1.63 |
| 溶解性 | DMSO 95 mg/mL Water <1 mg/mL Ethanol 95 mg/mL |
| 存贮条件 | 储存温度-20°C |
| 密度 | 1.3500 |
| 应用 | A competitive inhibitor of EDG-2, EDG-4, and EDG-7. |
| 产品介绍 | Ki16425是竞争性的可逆的LPA拮抗剂，对LPA1，LPA2和LPA3的Ki分别为0.34 μM，6.5 μM和0.93 μM，而对LPA4，LPA5和LPA6无活性。 |
| 生化机理 | Kil6425 preferentially inhibits LPA1- and LPA3-mediated responses but has only a moderate effect on LPA2. Ki16425 inhibits the LPA-induced Ca(2+) response in THP-1 cells, 3T3 fibroblasts, and A431 cells, but had only a marginal effect in PC-12 cells and HL-60 cells, which means that Ki16425 seems to be a useful tool for evaluating the involvement of specific LPA receptors in the short-term response to LPA. Ki16425 inhibits long-term DNA synthesis and cell migration as induced by LPA in Swiss 3T3 fibroblasts . Ki16425 reduces the LPA-induced activation of p42/p44 mitogen activated protein kinase (MAPK), while acting as a weak stimulator of p42/p44 MAPK on its own, properties typical of a protean agonist. Ki16425 also significantly reduces the NGF-induced stimulation of p42/p44 MAPK and inhibited NGF-stimulated neurite outgrowth in PC-12 cells. |
| 别名 | Ki-16425; Ki 16425; 3-[[[4-[4-[[[1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]苯基]甲基]硫基]丙酸;Ki-16425; Ki 16425; 3-[[[4-[4-[[[1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]phenyl]methyl]thio]-propanoic acid |
Ki16425,LPA1和LPA3受体拮抗剂
Ki16425 （订货以英文为准）
编号：K126742
CAS号：355025-24-0
分子式：C23H23CLN2O5S
分子量：474.96
| 产品名称 | Ki16425 |
| 中文名称 | Ki16425,LPA1和LPA3受体拮抗剂 |
| CAS号 | 355025-24-0 |
| 分子式（M.F.） | C23H23CLN2O5S |
| 分子量（M.W.） | 474.96 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 2606.00
356234-5mL
¥ 81.00
P0017C-500mL
¥ 120.00
P0017B-250mL
¥ 328.00
W4201820250-25mL
¥ 450.00
G769603-(11X10ml)/EA
¥ 450.00
O769595-(11X10ml)/EA
¥ 450.00
Y769597-(11X10ml)/EA
¥ 450.00
B769593-(11X10ml)/EA
党沛 
